Skip to main content
D

DLT

DLT provides a queryable intelligence platform that aggregates comprehensive data on longevity‑focused biotech companies, clinics, technologies, financing, IP, and scientific signals into a living dataset.

London, United KingdomFounded 19971710K+ followers
Updated 2 months ago

Funding

$70M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.

SC
Funding rounds are not available yet.

Founders

Founder details are not available yet.

Product

Problem

Information on longevity companies, clinics, and emerging trends is scattered across disparate sources, making it difficult for investors, researchers, and health professionals to obtain a comprehensive, up‑to‑date view of the sector.

Solution

DLT aggregates data on longevity‑focused biotech firms, clinics, technologies, financing, intellectual property, and scientific signals into a single, queryable dataset. The platform enriches each entry with detailed attributes such as target aging hallmarks, disease focus, clinical stage, and financial metrics. An AI‑powered analytics engine enables users to run linear and non‑linear analyses, identify emerging opportunities, and track market dynamics in real time. DLT also offers a curated directory of leading longevity clinics, including diagnostics, interventions, and support services, as well as a free daily newsletter that delivers the latest science, investment activity, and industry insights. Together, these tools provide a centralized intelligence hub for decision‑making across the longevity ecosystem.

Target Audience

Primary users are investors, corporate strategy teams, biotech founders, and pharma executives seeking data‑driven insights, as well as clinicians and consumers looking for vetted longevity clinics.

Features

  • Comprehensive database of 900+ longevity biotech companies with fields for finance, technology, IP, team, drug assets, clinical stage, aging hallmarks, disease focus, and mechanism of action
  • AI‑driven trend analysis allowing linear and non‑linear modeling of company performance and sector breakthroughs
  • Searchable, queryable platform that lets users filter by criteria such as target pathways, therapeutic modality, or investment round
  • Curated Longevity Clinics Directory evaluating clinics on diagnostics, interventions, and support pillars, with pricing ranges for services
  • Daily free newsletter summarizing new scientific findings, investment deals, and innovation updates
  • API access for integration of DLT data into corporate research pipelines or investment workflows
This profile is AI-generated and may contain inaccuracies.